Abstract
Clinical trials are the backbone for advancing therapeutic options for patients diagnosed with cancer. Yet only 7.1% of patients with cancer participate in clinical trials in the United States. In this article, we review some of the reasons for poor accrual and discuss potential solutions.
| Original language | English |
|---|---|
| Pages (from-to) | 3655-3657 |
| Number of pages | 3 |
| Journal | Clinical Cancer Research |
| Volume | 30 |
| Issue number | 17 |
| DOIs | |
| State | Published - Sep 1 2024 |
Fingerprint
Dive into the research topics of 'Novel Therapies in Cancer: Trials and Tribulations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver